Total trials
573
Active
115
Phase 3
2
Total enrollment
88,905
Pipeline matrix
Showing 20 of 20 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Adrenaline | — | — | — | — | — | 1 | |
| 0.9 % sodium chloride | — | — | — | — | — | 1 | |
| Romosozumab and Denosumab Combination Therapy | — | — | — | — | — | 1 | |
| Romosozumab Prefilled Syringe [Evenity] | — | — | — | — | — | 1 | |
| Denosumab | — | — | — | — | — | 1 | |
| Rivaroxaban plus immunosupression | — | — | — | — | — | 1 | |
| propofol | — | — | — | — | — | 3 | |
| Saline | — | — | — | — | — | 1 | |
| Dexamethasone | — | — | — | — | — | 1 | |
| Prilocaine | — | — | — | — | — | 1 | |
| Bupivacaine | — | — | — | — | — | 1 | |
| Postoperative Analgesia Protocol | — | — | — | — | — | 1 | |
| Opioid-free Anesthesia | — | — | — | — | — | 1 | |
| Opioid based Anesthesia | — | — | — | — | — | 1 | |
| Sevofluorane | — | — | — | — | — | 1 | |
| Phenol | — | — | — | — | — | 1 | |
| Tociliuzumab | — | — | — | — | — | 1 | |
| Infliximab | — | — | — | — | — | 1 | |
| Adalimumab | — | — | — | — | — | 1 | |
| Certolizumab Pegol | — | — | — | — | — | 1 |
Next readouts
- 2025-11
- 2026-06-01
- 2026-10-15
- 2026-12-01
- 2026-12-09
- 2026-12-15
- 2027-04-01
- 2027-06
- 2027-10-01
- 2027-12-15
Top conditions
- Cerebral Palsy15
- Stroke13
- Pain13
- Periodontitis12
- Anxiety10
- Central Sensitisation9
- Postoperative Pain8
- Lumbar Radiculopathy8
Frequently asked questions about Marmara University
- How many clinical trials does Marmara University have on ClinicalTrials.gov?
- Marmara University is listed as the lead sponsor on 573 clinical trials in ClinicalTrials.gov, 115 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Marmara University's trials are in Phase 3?
- 2 of Marmara University's trials are in Phase 3, spread across 20 active drug programs.
- What therapeutic areas does Marmara University focus on?
- Marmara University's most-studied conditions on ClinicalTrials.gov are Cerebral Palsy, Stroke, Pain, Periodontitis, Anxiety.
- When are Marmara University's next clinical trial readouts?
- Marmara University has 10 upcoming primary-completion readouts tracked here; the soonest is “Comparison of Ganglion Impar Radiofrequency Ablation and Phenol Neurolysis Techniques for Chronic Coccydynia Treatment”, expected around 2025-11.